Previously Unrecognized Trends in Diabetes Consumption Clusters in Medicare

Medicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.
Published Online: July 16, 2013
A. Enrique Caballero, MD; Jaime Davidson, MD; Angelo Elmi, PhD; James Gavin, MD, PhD; Kenyatta Lee, MD; Gail L. Nunlee-Bland, MD; Farhad Zangeneh, MD; and Gary A. Puckrein, PhD
Objective: To examine the annual cost profiles of Medicare beneficiaries with diabetes to identify patterns in their consumption of benefits.

Methods: Retrospective expenditure data were collected from Medicare records. Beneficiaries with diabetes were grouped into 5 consumption clusters ranging from “crisis consumers” at the high end to “low consumers” at the low end.

Results: The percentages of beneficiaries and expenditures for the consumption clusters remained generally constant from year to year. As expected, most of Medicare’s budget each year was spent on crisis, heavy, and moderate consumers. However, a notable proportion of low and light consumers from one year go on to become crisis and heavy consumers in subsequent years. A review of total 2001 through 2006 inpatient costs for the year 2000 clusters revealed that 47% of these costs were for year 2000 low and light consumers and only 27% were for year 2000 crisis and heavy consumers.

Conclusions: This analysis revealed previously unrecognized trends, whereby a notable proportion of low and light consumers during one year went on to become crisis and heavy consumers in subsequent years, representing a large proportion of inpatient costs. These findings have important implications for disease management programs, which typically focus intervention efforts exclusively on crisis and heavy consumers.

Am J Manag Care. 2013;19(7):541-548
This study analyzed annual cost profiles of Medicare beneficiaries with diabetes to identify patterns in their consumption of benefits.
  • The consumption clusters were very dynamic, with patients migrating from one consumption cluster to another each year.

  • A notable proportion of low and light consumers in one year went on to become crisis and heavy consumers in subsequent years.

  • This previously unrecognized migration from the lowest to the highest consumption clusters has important implications for the design of diabetes disease management program
Previous studies have demonstrated that a relatively small proportion of Medicare beneficiaries are the principal consumers of Medicare benefits.1-6 By comparing healthcare expenditures over a number of years, Berk and Monheit2 noted that there is a large amount of stability in the spending distribution over time. Because of the stable, skewed distribution of healthcare expenditures, the  prevailing approach to reducing healthcare spending has been to focus on those who are receiving large amounts of care.

However, it has recently become clear that disease management programs that focus on those receiving the largest amounts of care have not been successful. A recent report from the Congressional Budget Office describes an evaluation of Medicare’s demonstration projects on disease management.7 Six major disease management and care coordination demonstrations were evaluated by independent researchers. The results showed that most programs did not reduce Medicare spending, despite the fact that the programs specifically targeted beneficiaries who were high users of healthcare services.7

Our study extends the previous work by reviewing consumption and hospitalization patterns for fee-for-service Medicare beneficiaries living with diabetes. Consistent with previous findings, the proportions of patients in the various spending clusters were stable over time. However, when the behavior of individual beneficiaries was studied further it became clear that the populations in the spending clusters were dynamic, reconstituted each year while retaining the same proportional dimensions, as beneficiaries migrated from 1 cluster to another within definable parameters. These findings show that there is a previously unreported trend for beneficiaries in the lowest-spending clusters to transition to the highest-spending clusters in subsequent years. We discuss the potential implications  these findings for future approaches to reducing healthcare spending.


Retrospective expenditure data were collected from Medicare records. Medicare patients with diabetes were identified with an algorithm that required at least 1 inpatient, skilled nursing facility, or home health agency claim, or 2 Health Options Program or carrier (defined as Medicare administrative contractors or carriers that oversee the administration of both Medicare part A and part B policies) claims with the following diagnosis codes (any diagnosis on the claim) during the 2-year period: 249.00, 249.01, 249.10, 249.11, 249.20, 249.21, 249.30, 249.31, 249.40, 249.41, 249.50, 249.51, 249.60, 249.61, 249.70, 249.71, 249.80, 249.81, 249.90, 249.91, 250.00, 250.01, 250.02, 250.03, 250.10, 250.11, 250.12, 250.13, 250.20, 250.21, 250.22, 250.23, 250.30, 250.31, 250.32, 250.33, 250.40, 250.41, 250.42, 250.43, 250.50, 250.51, 250.52, 250.53, 250.60, 250.61, 250.62, 250.63, 250.70, 250.71, 250.72, 250.73, 250.80, 250.81, 250.82, 250.83, 250.90, 250.91, 250.92, 250.93, 357.2, 362.01, 362.02, and 366.41.

An annual cost profile for each Medicare fee-for-service beneficiary with diabetes for the years 2000 through 2006 was constructed using a unique beneficiary identifier to link the Beneficiary Annual Summary Files to Medicare’s Chronic Condition Data Warehouse flags, which identified beneficiaries who received Medicare reimbursements for diabetes.8 Total annual Medicare expenditures for each beneficiary with diabetes were calculated as the sum of all reimbursements made for inpatient and outpatient care, skilled-nursing facilities, carriers, durable medical goods, and home health and hospice care during a calendar year. In 2000, there were 106,995 (2.1%) diabetes beneficiaries whose primary payer for their medical expenses was not Medicare. Medicare total reimbursements therefore did not reflect their real insured healthcare expenditures. We removed such beneficiaries from study for the years 2000 through 2006. In 2000, there were 1376 (0.03%) diabetes beneficiaries with negative Medicare reimbursement values. Among these beneficiaries, 141 were removed because Medicare was not the primary payer of their medical expenses. For each year, the study included beneficiaries enrolled in Medicare part A and part B for at least 10 months and excluded all beneficiaries enrolled in Medicare Advantage because of the lack of complete reimbursement data. Beneficiaries were only removed from the study when they had at least 1 month of managed care for the year. The date of the death of a beneficiary was determined by the date given in the summary file.

Statistical Analysis

All analyses were conducted with SAS software, version 9.1 (SAS Institute Inc, Cary, North Carolina). On the basis of their annual cost profiles, beneficiaries with diabetes were grouped into 5 consumption clusters. Simple percentages were used to describe patterns of Medicare expenditures for the clusters: (1) crisis consumers (beneficiaries accounting for the 99th percentile [top 1%] of aggregate Medicare payments); (2) heavy consumers (90th through 98th percentiles); (3) moderate consumers (75th through 89th percentiles); (4) light consumers (50th through 74th percentiles); and (5) low consumers (1st through 49th percentiles).

An analysis was performed to determine whether the annual repopulation of a cluster followed any discernible pattern. Percentages were calculated to ascertain what proportions of the beneficiaries in a cluster migrated from one of the prior year’s consumption clusters. For example, what percentages of crisis consumers in 2001 were crisis, heavy, moderate, light, or low consumers in 2000? These migration studies were conducted for each of the clusters for the years 2001 through 2006. Once these calculations were completed, a comparison was made to determine whether the migration patterns among clusters were stable, with similar proportions from one year to the next.

The influence that expenditures for inpatient care had on migration patterns was examined by calculating reimbursements for hospitalization for the 5 consumption clusters from 2000 through 2006. Percentages were derived by dividing total expenditures for inpatient care by the total of all expenditures in a given year.

The annual risk for hospitalization for each of the 5 clusters in a given year was obtained by following each cluster from each year as a distinct cohort. For example, crisis consumers in the year 2000 were analyzed for their risk for inpatient stays in the succeeding years (2001-2006). Cluster members who did not remain fee-for-service beneficiaries from 2000 through 2006 were excluded from the analysis. Hospitalization in a given year was defined as a yes/no variable based on whether or not a beneficiary in a cluster had a record of any inpatient stay during a calendar year; a logistic regression analysis was conducted to determine an annual aggregated risk for hospitalization for each cluster based on its members’ prior histories of hospitalization.

To distinguish the percentage of total inpatient costs for the years 2001 through 2006 attributable to a particular year 2000 consumption cluster, the calculation included the sum of all inpatient costs for the years 2001 through 2006 for a cluster (the numerator) divided by all hospitalization costs for the same period for all year 2000 clusters (the denominator).


Table 1 shows the annual expenditures and populations of each consumer cluster. As expected, a small proportion of the population (ie, the crisis and heavy consumers) represented the majority of the expenditures (Figure 1). Analysis of the clusters over time revealed that they were stable in the sense that the percentages of benefi ciaries and expenditures that differentiated each cluster remained generally constant from one year to the next (Figure 2). For example, crisis consumers ranged between 2% and 3% of all beneficiaries, and 23% to 25% of total reimbursements were for their care.

Of all the clusters, low consumers were the most numerous. Each year they accounted for approximately 32% of all fee-for-service beneficiaries living with diabetes. Total  reimbursements for this cluster were approximately 2% of all dollars spent on diabetes in the program. Together, low and light consumers represented 61% of Medicare beneficiaries living with diabetes, but only 9% of the program’s dollars went to their care each year. The mean per capita expenditure for low consumers was $494 in 2000, increasing to $815 in 2006; the corresponding expenditures for crisis consumers were $95,847 in 2000 and $126,789 in 2006. Of total reimbursements, 91% were spent on crisis, heavy, and moderate consumers, who represented 39% of beneficiaries.

The populations within the clusters were dynamic, reconstituted each year as beneficiaries migrated from one cluster to another. Migration was not unidirectional; some benefi ciaries moved to higher-cost clusters and some moved to lowercost clusters. The percentages of beneficiaries moving among clusters had stable patterns. Table 2 summarizes annual migration into the crisis-consumer and low-consumer clusters. Discernible patterns were evident. Each year, for example, approximately 20% of crisis consumers remained in that cluster, and about 8% migrated to become low consumers. Routinely, about 39% of crisis consumers had been heavy consumers in the prior year. About 60% of low consumers remained in the cluster from one year to the next. Fewer than 1% of low consumers had been crisis consumers in the previous year.

PDF is available on the last page.
Recommended Articles
In the fourth year of the Hospital Readmissions Reduction Program, which makes hospitals pay closer attention to their patients after discharge, half of the nation’s hospitals will be penalized by Medicare because of their readmissions.
The diagnosis and management of patients with dementing illnesses can be challenging, but the cost of misdiagnosing dementia as Alzheimer’s disease can be as high as $14,000 a year, according to a study published in Alzheimer’s & Dementia.
A study published in the American Journal of Preventive Medicine shows that grip strength of young, healthy adults could prove useful in the diagnosis of diabetes and hypertension.
The announced price for alirocumab, the first PCSK9 inhibitor approved for use in the US, was the top story in managed care this week. Also, HHS announced $100 million available to combat substance abuse, and Medicare and Medicaid turn 50 years old.
Measure definitions to estimate the effects of cost sharing on adherence to medications prescribed together (ie, concurrent adherence) are lacking.